© 2002 by Oxford University Press
Journal of the National Cancer Institute, Vol. 94, No. 11, 861-860,
June 5, 2002
© 2002 Oxford University Press
CORRESPONDENCE |
Re: All-Cause Mortality in Randomized Trials of Cancer Screening
Affiliations of authors: T. Church, School of Public Health, University of Minnesota, Minneapolis; F. Ederer, School of Public Health, University of Minnesota, and The EMMES Corporation, Rockville, MD; J. Mandel, Exponent, Inc., Menlo Park, CA.
Correspondence to: Timothy R. Church, Ph.D., Division of Environmental and Occupational Health, School of Public Health, MMC 807, 420 Delaware St. SE, Minneapolis, MN 55455 (e-mail: trc@cccs.umn.edu).
To support their argument that results of cancer screening trials based on disease-specific mortality are unreliable, Black et al. (1) compared the treatment effect measured by disease-specific mortality with the effect measured by all-cause mortality in 12 such trials. They
REFERENCES